Yunsung F&C (372170) Stock Outlook 2026: A Battery Mixing Specialist, a Dry-Electrode Bet and the Risks

Is Yunsung F&C a real turnaround or a theme waiting for proof?

My read: it is a credible small-cap option on battery factory spending, not yet a recovery story. The 2025 slump is a fact. The 2026 rebound is a hypothesis, and the best evidence for it is that the company leads a government-backed dry-electrode project. That is worth something. It is not the same as orders on the books.

Yunsung builds mixers, the machines at the very front of an electrode line where powders and binder become slurry. When battery makers were building plants at full speed, mixing orders came quickly. When EV growth cooled and cell makers pushed out new lines, those orders dried up just as fast. Equipment stocks work that way. Customers open their wallets, or they do not.

So three questions decide whether this is worth owning. How strong is Yunsung’s position in a narrow step of the process? Is dry-electrode technology a real shift or a long research topic? And does the company have the balance sheet to wait if the rebound comes late?

---

What does mixing do, and why is it the starting point of cell quality?

An electrode is a thin metal foil coated with a paste of active material. That paste is a precise blend of cathode or anode powder, conductive carbon, binder and solvent, added in a set order at a set speed. Think of baking: if the dough has lumps or trapped air, nothing you do in the oven fixes it.

Batteries are less forgiving than bread. Clumped particles produce uneven coating, and uneven coating changes how current flows inside the cell, which shows up as capacity fade, shorter life and, in the worst case, heat. Mixing also sits first in the sequence, so a flaw created here is only discovered after coating, pressing and assembly, when the cost has already piled up.

For that reason, cell makers buy mixers on reproducibility and track record more than price. A mixer proven on one production line is often copied onto the next. That makes Yunsung stickier than a plain hardware vendor. Sticky is not the same as locked in, though. Mixing is a field where larger equipment groups and overseas competitors can compete if they want the business.

Item	What it is	Why it matters
Core product	Electrode slurry mixers, feeding systems	First process step, so quality stakes are high
Revenue trigger	Customer line expansions, new plants	Tied directly to capex cycles
Switching cost	Proven tools reused when lines are cloned	Helps defend existing customers
Weakness	One process step, few customers	Little cushion in downturns

---

Was the 2025 slump temporary or structural?

The cause was not inside Yunsung. EV sales growth slowed, US policy on EV incentives and battery manufacturing credits became harder to forecast, and cell makers delayed or resized factory plans in North America and Europe. Equipment suppliers feel that first. Orders thin out, backlog shrinks and revenue follows a quarter or two later.

Understanding that sequence gives you two practical rules. Recovery shows up late in equipment companies: utilization rises at the cell maker, then expansion gets approved, then tools are ordered, then revenue is recognized. And the first sign of recovery appears in orders, not revenue. If you wait for sales to turn, you are behind.

I do not call 2025 purely temporary. EV adoption growing slower than earlier forecasts is a lasting change. But batteries are not going away. Energy storage systems for utilities and data centers, plus the next generation of cell designs, can create fresh demand for equipment. The honest state of play is that nobody knows the speed of recovery, so you measure it.

Customer-dependent equipment cycles show up in other corners of the Korean market as well. My Vatech outlook walks through a dental imaging maker whose results also rise and fall with its customers’ capital budgets, which is a useful contrast with a battery-line supplier.

---

What is dry-electrode processing, and what does leading the national project mean?

Most electrodes today are made wet. Slurry is coated on foil, and then a long drying oven drives off the solvent. That oven is big, burns a lot of electricity and requires solvent recovery equipment. It is one of the heavier line items in the cost of a battery plant.

Dry-electrode processing drops the solvent. Powdered active material and binder are mixed, pressed into a film and bonded to the current collector. In principle that removes much of the drying hardware and cuts energy use and plant footprint. Some developers also point to energy-density benefits. Tesla’s work after acquiring Maxwell Technologies put the idea on every battery investor’s radar, and Korean cell makers, materials suppliers and equipment companies are all working on their own versions.

Why would leading a Korean government project matter for a mixer company? Because blending powder uniformly is still the heart of a dry process, and it connects to the film-forming equipment that comes next. Mixing know-how is the natural entry point. A lead role means the company develops prototypes alongside cell makers and materials suppliers, and that experience becomes a reference when production orders are awarded.

Do not stretch the point. A national project is a credibility signal, not a revenue guarantee. Dry-electrode lines still face open questions on yield, film uniformity and continuous roll-to-roll operation. Foreign players have a head start in some areas, and no one outside the cell makers knows when a Korean producer will commit to a production line. I treat this as an option that may pay off in 2027 or later, not an event that shows up in 2026 results.

Item	Wet electrode	Dry electrode
Solvent	Required (such as NMP)	None
Drying	Long, energy-hungry ovens	Greatly reduced or eliminated
Equipment change	Current production standard	New mixing and film-forming tools
Maturity	Proven at scale	Still being qualified
Yunsung angle	Existing revenue base	New order option

---

How does Yunsung compare with other battery equipment makers?

Battery equipment is divided by process step. Companies that make coating, roll pressing, stacking or formation equipment take larger checks when a line goes up. Mixing is a smaller share of total line investment, which means Yunsung earns less per order than those peers.

Item	Yunsung F&C	Coating and pressing makers	Assembly and formation makers
Process	Mixing (slurry)	Coating, calendering	Stacking, formation
Share of line spend	Smaller	Larger	Larger
Strength	Process know-how, repeatability	Precision coating	Automation scale
Cycle sensitivity	High	High	High
Main risk	Customer concentration, single step	Price competition, key-customer reliance	Technology shifts, order swings

Nobody in this group is immune from the cycle. One difference is worth noting: mixers are often ordered early in a line build, so they can act as an early signal when factory investment restarts. That is the most practical piece of the Yunsung case. If the spending cycle turns, the front-end equipment tends to move first.

---

How risky are customer concentration and the capex cycle?

The weak point of a small equipment company is dependence on a handful of customers. If the main buyers are Korea’s three big cell makers and their overseas plants and joint ventures, one delayed project can move a quarter. What looks like several customers may in reality be several factories belonging to the same group.

Auto suppliers share that trait. Part makers tied to Hyundai and Kia ride the carmaker’s launch schedule, a dynamic my HL Mando outlook explains in the context of steering and autonomy systems. Different industry, same lesson: one big customer sets the cycle.

The demand chain runs from automakers to cell makers to equipment makers. If automakers push back electrification plans, cell investment shrinks and tool orders follow. Watching the auto side first is a cheap way to guess where equipment orders are headed.

---

What is the stock pricing in, and what is it not?

Equipment small caps usually fall hard when results are bad and rally on hints of recovery before results show it. That makes valuation tricky: you should value normalized earnings, not current earnings, and nobody knows what normal is. Calling a stock cheap against peak-cycle profit is a classic value trap, because the peak may have been an unusual burst of capital spending.

I think in two scenarios. In the cautious one, EV growth stays moderate and cell makers expand through smaller upgrades and storage lines, so Yunsung climbs out of losses without getting close to its old high. In the optimistic one, dry-electrode technology is adopted on a production line at one or more customers, and Yunsung wins mixing and film-forming tools together, which changes the revenue profile. Which one the price embeds is for you to judge, but I would bet that the optimistic timeline lands after 2026, not within it.

Captive customer relationships create a very different risk profile, as in my Cheil Worldwide outlook, where one parent drives most of the business. Yunsung is not captive. It wins orders in competition, which means less stability and more upside from new technology.

---

What are the real risks?

Technology delay. If dry electrodes reach mass production later than hoped, the center of the rebound story disappears and the stock can reprice before earnings show anything.

Order gaps. Equipment revenue is lumpy. Salaries and research costs continue in quarters with no orders, and a thin cash cushion shortens the runway.

Customer bargaining power. In a weak investment climate, cell makers push hard on equipment pricing. Winning an order does not guarantee a healthy margin.

Competition. China, Japan and Europe all have mixer builders. Chinese equipment pricing is hard to match in overseas factory bids.

Theme volatility. When dry electrodes or next-generation cells make headlines, volume spikes and prices jump first. Late buyers pay for hope and take the loss when it fades.

Policy. US and European battery and EV policy shapes how fast overseas plants get built. A Korean equipment maker has no control over it.

---

How would a US investor approach a KOSDAQ battery stock?

Scenario 1: A small satellite position, scaled in on evidence

This belongs on the edge of a portfolio, not in the middle. If recovery has not shown up in orders, sizing it as a core holding is a bet, not an investment. Decide the loss you can live with first, then size the position so that number is small relative to your total assets. Add on order announcements and quarterly results rather than all at once.

Scenario 2: Access, currency and taxes

There is no US-listed version, so you need a broker with direct Korean market access. Compare commissions, the won-to-dollar conversion spread and any account fees. Spreads on thinly traded KOSDAQ names can cost more than the commission itself. As a US taxpayer you report worldwide income, so track dividends, any Korean withholding and gains in dollars. A weaker won hurts your dollar return even if the share price in won is flat. Taxation of gains from Korean shares has special rules for non-residents and treaty relief, so check with a tax professional. For the US side of capital gains, our capital gains tax guide lays out holding periods and netting of losses.

Scenario 3: Pair equipment with materials to spread risk

The battery chain splits into materials, equipment, cells and parts. Equipment reacts fastest and swings hardest to the investment cycle. Materials are steadier, especially when a company has a base business that carries it, as in my Dongkuk Industries outlook, which looks at a steel maker moving into battery materials. Mixing the two reduces the shock from a single downturn.

---

What metrics should you watch every quarter?

New orders and backlog. Revenue is a result of past orders, and orders predict future revenue. Check whether backlog growth comes from one large one-off contract or a steady flow.

Customer and regional mix. Look for dependence on a single buyer or one country. A rising overseas share suggests less reliance on Korean investment cycles.

Operating margin. Orders with weak margins mean the company is losing price negotiations. I want to see margin recovery before or alongside revenue growth.

Dry-electrode milestones. Look for named customers, prototype deliveries, evaluation passes and pilot-line orders. A press release with a customer name and a quantity carries far more weight than vague wording about development completion.

Balance sheet. Cash, borrowings and working capital decide how long the company can wait if the rebound slips.

When all five point the same direction, the turnaround is showing up in numbers. If one lags, hope is ahead of the business.

---

This article is for informational purposes only and is not investment, tax or legal advice, nor a recommendation to buy or sell any security. Investing involves risk, including loss of principal, and foreign small-cap stocks carry additional liquidity and currency risk. Company details reflect the time of writing, so confirm current filings and consult a licensed professional before you invest.